| Welcome to the Dorset Formulary |
Useful Links
|
News Feed
DMAG - July 2016 Summary of recommendations is now available here
For information : Fentanyl sublingual tablets -RecivitŪ - have been withdrawn from the UK market
NEW : Urticaria Pathway
NEW : Primary care treatment of DVT (with NOAC) pathway Available here
DOAC cards - Electronic version of Direct Oral Anticoagulant (DOAC) alert card is now available HERE
New : Guidelines outlining the duty of care regarding drugs recommended by outpatient clinics avaiable here
>>> more news |
Getting started: Use the search tool to find medicine of interest or browse by BNF chapter using the 'Chapters' Menu at top of page. The Dorset Formulary aims to provide information on medicines supporting safe, evidence-based, cost-effective practice. Whilst the formulary contains links to relevant policies and guidelines, the prescriber retains the responsibility for the appropriate use of this information.
For further information on the development of the Dorset Formulary and participating organisations, please go to the About page.
Comments about any aspect of the formulary can be made by using the feedback tab at the top of this page.
|
|
